VBI Vaccines OverviewVBI Vaccines EBIT
EBIT (Earnings Before Interest and Taxes) analysis for VBIV.
Quarterly EBIT
-$12.25M
↑ 37.23% YoY
As of Mar 31, 2024
Annual EBIT (TTM)
-$51.85M
↑ 39.29% YoY
Trailing 12 months ending Mar 31, 2024
VBI Vaccines OverviewEBIT (Earnings Before Interest and Taxes) analysis for VBIV.
As of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024